Antibiotic origami: selective formation of spirotetronates in abyssomicin biosynthesis

The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs an enzyme-catalysed intramolecular Diels-Alder reac...

Full description

Saved in:
Bibliographic Details
Published inChemical science (Cambridge) Vol. 15; no. 34; pp. 14009 - 14015
Main Authors Mbatha, Sbusisiwe Z, Back, Catherine R, Devine, Andrew J, Mulliner, Hannah M, Johns, Samuel T, Lewin, Harry, Cheung, Kaiman A, Zorn, Katja, Stach, James E M, Hayes, Martin A, van der Kamp, Marc W, Race, Paul R, Willis, Christine L
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 12.08.2024
The Royal Society of Chemistry
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs an enzyme-catalysed intramolecular Diels-Alder reaction, which proceeds one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts.
AbstractList The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs via an enzyme-catalysed intramolecular Diels–Alder reaction, which proceeds via one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts. The molecular origins of stereoselectivity in enzyme catalysed Diels–Alder reactions in abyssomicin biosynthesis are determined and spirotetronates prepared with the creation of 3 new stereocentres.
The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs via an enzyme-catalysed intramolecular Diels–Alder reaction, which proceeds via one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts.
The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs via an enzyme-catalysed intramolecular Diels-Alder reaction, which proceeds via one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts.The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs via an enzyme-catalysed intramolecular Diels-Alder reaction, which proceeds via one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts.
The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral activities. The biosynthesis of the characteristic abyssomicin spirotetronate core occurs an enzyme-catalysed intramolecular Diels-Alder reaction, which proceeds one of two distinct stereochemical pathways to generate products differing in configuration at the C15 spirocentre. Using the purified spirotetronate cyclases AbyU (from abyssomicin C/atrop-abyssomicin C biosynthesis) and AbmU (from abyssomicin 2/neoabyssomicin biosynthesis), in combination with synthetic substrate analogues, here we show that stereoselectivity in the spirotetronate-forming [4 + 2]-cycloaddition is controlled by a combination of factors attributable to both the enzyme and substrate. Furthermore, an achiral substrate was enzymatically cyclised to a single enantiomer of a spirocyclic product. X-ray crystal structures, molecular dynamics simulations, and assessment of substrate binding affinity and reactivity in both AbyU and AbmU establish the molecular determinants of stereochemical control in this important class of biocatalysts.
Author Cheung, Kaiman A
Back, Catherine R
Johns, Samuel T
Mulliner, Hannah M
Zorn, Katja
Mbatha, Sbusisiwe Z
van der Kamp, Marc W
Devine, Andrew J
Stach, James E M
Lewin, Harry
Willis, Christine L
Hayes, Martin A
Race, Paul R
Author_xml – sequence: 1
  givenname: Sbusisiwe Z
  orcidid: 0000-0002-4097-1034
  surname: Mbatha
  fullname: Mbatha, Sbusisiwe Z
  email: chris.willis@bristol.ac.uk
  organization: School of Chemistry, University of Bristol Bristol BS8 1TS UK chris.willis@bristol.ac.uk
– sequence: 2
  givenname: Catherine R
  surname: Back
  fullname: Back, Catherine R
  organization: School of Biochemistry, University of Bristol Bristol BS8 1TD UK
– sequence: 3
  givenname: Andrew J
  orcidid: 0000-0002-4200-5542
  surname: Devine
  fullname: Devine, Andrew J
  email: chris.willis@bristol.ac.uk
  organization: School of Chemistry, University of Bristol Bristol BS8 1TS UK chris.willis@bristol.ac.uk
– sequence: 4
  givenname: Hannah M
  surname: Mulliner
  fullname: Mulliner, Hannah M
  email: chris.willis@bristol.ac.uk
  organization: School of Chemistry, University of Bristol Bristol BS8 1TS UK chris.willis@bristol.ac.uk
– sequence: 5
  givenname: Samuel T
  surname: Johns
  fullname: Johns, Samuel T
  organization: School of Biochemistry, University of Bristol Bristol BS8 1TD UK
– sequence: 6
  givenname: Harry
  surname: Lewin
  fullname: Lewin, Harry
  organization: School of Biochemistry, University of Bristol Bristol BS8 1TD UK
– sequence: 7
  givenname: Kaiman A
  orcidid: 0000-0002-2431-3250
  surname: Cheung
  fullname: Cheung, Kaiman A
  email: chris.willis@bristol.ac.uk
  organization: School of Chemistry, University of Bristol Bristol BS8 1TS UK chris.willis@bristol.ac.uk
– sequence: 8
  givenname: Katja
  surname: Zorn
  fullname: Zorn, Katja
  organization: Compound Synthesis and Management, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca Pepparedsleden 1 431 83 Mölndal Sweden
– sequence: 9
  givenname: James E M
  surname: Stach
  fullname: Stach, James E M
  email: paul.race1@newcastle.ac.uk
  organization: School of Natural and Environmental Sciences, Newcastle University Newcastle Upon Tyne NE1 7RU UK paul.race1@newcastle.ac.uk
– sequence: 10
  givenname: Martin A
  orcidid: 0000-0002-2640-8464
  surname: Hayes
  fullname: Hayes, Martin A
  organization: Compound Synthesis and Management, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca Pepparedsleden 1 431 83 Mölndal Sweden
– sequence: 11
  givenname: Marc W
  orcidid: 0000-0002-8060-3359
  surname: van der Kamp
  fullname: van der Kamp, Marc W
  organization: School of Biochemistry, University of Bristol Bristol BS8 1TD UK
– sequence: 12
  givenname: Paul R
  orcidid: 0000-0003-0184-5630
  surname: Race
  fullname: Race, Paul R
  email: paul.race1@newcastle.ac.uk
  organization: School of Natural and Environmental Sciences, Newcastle University Newcastle Upon Tyne NE1 7RU UK paul.race1@newcastle.ac.uk
– sequence: 13
  givenname: Christine L
  orcidid: 0000-0002-3919-3642
  surname: Willis
  fullname: Willis, Christine L
  email: chris.willis@bristol.ac.uk
  organization: School of Chemistry, University of Bristol Bristol BS8 1TS UK chris.willis@bristol.ac.uk
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39144453$$D View this record in MEDLINE/PubMed
BookMark eNpdkd1rFTEQxYNUbK198Q-QBV9EuJpkstmNL6VcWxUKPvjxGrLZSZuym1wzuYX737v98KLOyxyYH4cznOfsIOWEjL0U_J3gYN6PijwH2QI-YUeSK7HSLZiDvZb8kJ0Q3fBlAEQru2fsEIxQSrVwxH6epRqHmGv0TS7xys3xQ0M4oa_xFpuQy-xqzKnJoaFNLLliLTm5itTE1LhhR5Tn6Be9uNAu1WukSC_Y0-AmwpPHfcx-XJx_X39eXX799GV9drny0ui60kq70SCAlp3u-jBIA4PqhUE_cpSh96OUUmndqwADjnxUyvAwBo5CySHAMTt98N1shxlHj6kWN9lNibMrO5tdtP9eUry2V_nWCgGi1y1fHN48OpT8a4tU7RzJ4zS5hHlLFrgB0SnQ_YK-_g-9yduSlv_uqK6XojXdQr19oHzJRAXDPo3g9q4y-1F9W99Xdr7Ar_7Ov0f_FAS_ATYFlMc
Cites_doi 10.1039/D4SC02908A
10.1016/j.chembiol.2016.04.002
10.1128/AAC.41.1.1
10.1002/cbic.202300382
10.1021/ol500111n
10.1002/anie.201301680
10.1002/cbic.201100172
10.1038/s41557-022-01104-x
10.1038/nsmb.3326
10.1146/annurev-cellbio-100814-125544
10.1093/emboj/19.6.1176
10.1016/j.bioorg.2014.03.010
10.1101/cshperspect.a018713
10.1021/acsomega.0c02776
10.1021/acs.orglett.8b01997
10.7164/antibiotics.57.271
10.1002/cjoc.202100081
10.1021/acs.orglett.0c01348
10.1002/anie.200502119
10.1039/c39870001625
10.1016/j.chembiol.2016.01.005
10.1002/anie.202213053
10.1039/C6OB02567F
10.1021/jacs.6b00232
10.1016/S0966-842X(97)01033-0
10.1016/j.tcb.2017.01.003
10.1016/j.tibs.2016.07.005
10.1016/j.tet.2017.07.034
ContentType Journal Article
Copyright This journal is © The Royal Society of Chemistry.
Copyright Royal Society of Chemistry 2024
This journal is © The Royal Society of Chemistry 2024 The Royal Society of Chemistry
Copyright_xml – notice: This journal is © The Royal Society of Chemistry.
– notice: Copyright Royal Society of Chemistry 2024
– notice: This journal is © The Royal Society of Chemistry 2024 The Royal Society of Chemistry
DBID NPM
AAYXX
CITATION
7SR
8BQ
8FD
JG9
7X8
5PM
DOI 10.1039/d4sc03253e
DatabaseName PubMed
CrossRef
Engineered Materials Abstracts
METADEX
Technology Research Database
Materials Research Database
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Materials Research Database
Engineered Materials Abstracts
Technology Research Database
METADEX
MEDLINE - Academic
DatabaseTitleList
Materials Research Database
MEDLINE - Academic
CrossRef
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 2041-6539
EndPage 14015
ExternalDocumentID 10_1039_D4SC03253E
39144453
Genre Journal Article
GrantInformation_xml – fundername: ;
  grantid: EP/S024107/1
– fundername: ;
  grantid: Unassigned
– fundername: ;
  grantid: BB/L01386X/1; BB/M012107/1; BB/M025624/1; BB/M026280/1; BB/T001968/1
– fundername: ;
  grantid: EP/L015366/1; EP/L016494/1
GroupedDBID -JG
0-7
0R~
53G
705
7~J
AAEMU
AAFWJ
AAIWI
AAJAE
AARTK
AAXHV
ABEMK
ABPDG
ABXOH
ACGFS
ACIWK
ADBBV
ADMRA
AEFDR
AENEX
AESAV
AFLYV
AFPKN
AGEGJ
AGRSR
AGSTE
AHGCF
AKBGW
ALMA_UNASSIGNED_HOLDINGS
ANUXI
AOIJS
APEMP
AUDPV
AZFZN
BCNDV
BLAPV
BSQNT
C6K
D0L
EE0
EF-
F5P
GROUPED_DOAJ
H13
HYE
HZ~
H~N
NPM
O-G
O9-
OK1
PGMZT
R7C
R7D
RAOCF
RCNCU
RNS
RPM
RRC
RSCEA
RVUXY
SKA
SKF
SKH
SKJ
SKM
SKR
SKZ
SLC
SLF
SLH
SMJ
AAYXX
CITATION
7SR
8BQ
8FD
JG9
7X8
5PM
ID FETCH-LOGICAL-c296t-646ad9e33627678fb293b4819ecd0e2f8cd22246684f3bed0d4490fdf0e142bf3
IEDL.DBID RPM
ISSN 2041-6520
IngestDate Tue Sep 17 21:27:38 EDT 2024
Tue Aug 27 04:54:14 EDT 2024
Fri Aug 30 09:40:13 EDT 2024
Wed Sep 04 12:47:06 EDT 2024
Wed Oct 02 05:20:48 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 34
Language English
License This journal is © The Royal Society of Chemistry.
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c296t-646ad9e33627678fb293b4819ecd0e2f8cd22246684f3bed0d4490fdf0e142bf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Contributed equally to this work.
ORCID 0000-0002-4097-1034
0000-0002-4200-5542
0000-0002-3919-3642
0000-0002-2640-8464
0000-0003-0184-5630
0000-0002-8060-3359
0000-0002-2431-3250
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318650/
PMID 39144453
PQID 3097821597
PQPubID 2047492
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11318650
proquest_miscellaneous_3093174368
proquest_journals_3097821597
crossref_primary_10_1039_D4SC03253E
pubmed_primary_39144453
PublicationCentury 2000
PublicationDate 20240812
PublicationDateYYYYMMDD 2024-08-12
PublicationDate_xml – month: 8
  year: 2024
  text: 20240812
  day: 12
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Cambridge
PublicationTitle Chemical science (Cambridge)
PublicationTitleAlternate Chem Sci
PublicationYear 2024
Publisher Royal Society of Chemistry
The Royal Society of Chemistry
Publisher_xml – name: Royal Society of Chemistry
– name: The Royal Society of Chemistry
References Moynihan (D4SC03253E/cit1f/1) 2014; 54
Wu (D4SC03253E/cit3a/1) 2014; 16
Byrne (D4SC03253E/cit12/1) 2016; 138
Zapf (D4SC03253E/cit15/1) 2005; 44
Kanchanabanca (D4SC03253E/cit3b/1) 2013; 52
Zamaraev (D4SC03253E/cit1d/1) 2017; 27
Seto (D4SC03253E/cit2b/1) 2014; 6
Davies (D4SC03253E/cit1h/1) 1997; 5
Song (D4SC03253E/cit6a/1) 2017; 73
Drazic (D4SC03253E/cit2a/1) 2016; 1864
Janke (D4SC03253E/cit1b/1) 2015; 31
Gottardi (D4SC03253E/cit7/1) 2011; 12
Zheng (D4SC03253E/cit3c/1) 2016; 15
Hirano (D4SC03253E/cit1a/1) 2016; 23
Kouzarides (D4SC03253E/cit1e/1) 2000; 19
Maschio (D4SC03253E/cit17/1) 2024; 15
Zheng (D4SC03253E/cit11/1) 2016; 23
Wunderlich (D4SC03253E/cit13/1) 2020; 22
Aksnes (D4SC03253E/cit1c/1) 2016; 41
Oikawa (D4SC03253E/cit4/1) 2016; 23
Murray (D4SC03253E/cit1g/1) 1997; 41
Riedlinger (D4SC03253E/cit5/1) 2004; 57
Ding (D4SC03253E/cit6c/1) 2021; 39
Devine (D4SC03253E/cit8/1) 2023; 62
Li (D4SC03253E/cit9/1) 2018; 20
Li (D4SC03253E/cit6b/1) 2020; 5
Wang (D4SC03253E/cit16/1) 2023; 15
Zorn (D4SC03253E/cit10/1) 2023; 24
Griffith (D4SC03253E/cit14/1) 1987; 21
References_xml – volume: 15
  start-page: 11572
  year: 2024
  ident: D4SC03253E/cit17/1
  publication-title: Chem. Sci.
  doi: 10.1039/D4SC02908A
  contributor:
    fullname: Maschio
– volume: 23
  start-page: 429
  year: 2016
  ident: D4SC03253E/cit4/1
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2016.04.002
  contributor:
    fullname: Oikawa
– volume: 41
  start-page: 1
  year: 1997
  ident: D4SC03253E/cit1g/1
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.41.1.1
  contributor:
    fullname: Murray
– volume: 24
  start-page: e202300382
  year: 2023
  ident: D4SC03253E/cit10/1
  publication-title: ChemBioChem
  doi: 10.1002/cbic.202300382
  contributor:
    fullname: Zorn
– volume: 16
  start-page: 1578
  year: 2014
  ident: D4SC03253E/cit3a/1
  publication-title: Org. Lett.
  doi: 10.1021/ol500111n
  contributor:
    fullname: Wu
– volume: 52
  start-page: 5785
  year: 2013
  ident: D4SC03253E/cit3b/1
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.201301680
  contributor:
    fullname: Kanchanabanca
– volume: 12
  start-page: 1401
  year: 2011
  ident: D4SC03253E/cit7/1
  publication-title: ChemBioChem
  doi: 10.1002/cbic.201100172
  contributor:
    fullname: Gottardi
– volume: 15
  start-page: 177
  year: 2023
  ident: D4SC03253E/cit16/1
  publication-title: Nat. Chem.
  doi: 10.1038/s41557-022-01104-x
  contributor:
    fullname: Wang
– volume: 23
  start-page: 1053
  year: 2016
  ident: D4SC03253E/cit1a/1
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/nsmb.3326
  contributor:
    fullname: Hirano
– volume: 31
  start-page: 473
  year: 2015
  ident: D4SC03253E/cit1b/1
  publication-title: Annu. Rev. Cell Dev. Biol.
  doi: 10.1146/annurev-cellbio-100814-125544
  contributor:
    fullname: Janke
– volume: 19
  start-page: 1176
  year: 2000
  ident: D4SC03253E/cit1e/1
  publication-title: EMBO J.
  doi: 10.1093/emboj/19.6.1176
  contributor:
    fullname: Kouzarides
– volume: 54
  start-page: 44
  year: 2014
  ident: D4SC03253E/cit1f/1
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2014.03.010
  contributor:
    fullname: Moynihan
– volume: 1864
  start-page: 1372
  year: 2016
  ident: D4SC03253E/cit2a/1
  publication-title: Biochem. Biophys. Acta
  contributor:
    fullname: Drazic
– volume: 6
  start-page: a018713
  year: 2014
  ident: D4SC03253E/cit2b/1
  publication-title: Cold Spring Harb. Perspect. Biol.
  doi: 10.1101/cshperspect.a018713
  contributor:
    fullname: Seto
– volume: 5
  start-page: 20548
  year: 2020
  ident: D4SC03253E/cit6b/1
  publication-title: ACS Omega
  doi: 10.1021/acsomega.0c02776
  contributor:
    fullname: Li
– volume: 20
  start-page: 4854
  year: 2018
  ident: D4SC03253E/cit9/1
  publication-title: Org. Lett.
  doi: 10.1021/acs.orglett.8b01997
  contributor:
    fullname: Li
– volume: 57
  start-page: 271
  year: 2004
  ident: D4SC03253E/cit5/1
  publication-title: J. Antibiot.
  doi: 10.7164/antibiotics.57.271
  contributor:
    fullname: Riedlinger
– volume: 39
  start-page: 1871
  year: 2021
  ident: D4SC03253E/cit6c/1
  publication-title: Chin. J. Chem.
  doi: 10.1002/cjoc.202100081
  contributor:
    fullname: Ding
– volume: 22
  start-page: 4955
  year: 2020
  ident: D4SC03253E/cit13/1
  publication-title: Org. Lett.
  doi: 10.1021/acs.orglett.0c01348
  contributor:
    fullname: Wunderlich
– volume: 44
  start-page: 6533
  year: 2005
  ident: D4SC03253E/cit15/1
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.200502119
  contributor:
    fullname: Zapf
– volume: 21
  start-page: 1625
  year: 1987
  ident: D4SC03253E/cit14/1
  publication-title: J. Chem. Soc. Chem. Commun.
  doi: 10.1039/c39870001625
  contributor:
    fullname: Griffith
– volume: 23
  start-page: 352
  year: 2016
  ident: D4SC03253E/cit11/1
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2016.01.005
  contributor:
    fullname: Zheng
– volume: 62
  start-page: e202213053
  year: 2023
  ident: D4SC03253E/cit8/1
  publication-title: Angew. Chem., Int. Ed.
  doi: 10.1002/anie.202213053
  contributor:
    fullname: Devine
– volume: 15
  start-page: 88
  year: 2016
  ident: D4SC03253E/cit3c/1
  publication-title: Org. Biomol. Chem.
  doi: 10.1039/C6OB02567F
  contributor:
    fullname: Zheng
– volume: 138
  start-page: 6095
  year: 2016
  ident: D4SC03253E/cit12/1
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.6b00232
  contributor:
    fullname: Byrne
– volume: 5
  start-page: 234
  year: 1997
  ident: D4SC03253E/cit1h/1
  publication-title: Trends Microbiol.
  doi: 10.1016/S0966-842X(97)01033-0
  contributor:
    fullname: Davies
– volume: 27
  start-page: 311
  year: 2017
  ident: D4SC03253E/cit1d/1
  publication-title: Trends Cell Biol.
  doi: 10.1016/j.tcb.2017.01.003
  contributor:
    fullname: Zamaraev
– volume: 41
  start-page: 746
  year: 2016
  ident: D4SC03253E/cit1c/1
  publication-title: Trends Biochem. Sci.
  doi: 10.1016/j.tibs.2016.07.005
  contributor:
    fullname: Aksnes
– volume: 73
  start-page: 5366
  year: 2017
  ident: D4SC03253E/cit6a/1
  publication-title: Tetrahedron
  doi: 10.1016/j.tet.2017.07.034
  contributor:
    fullname: Song
SSID ssj0000331527
Score 2.4629488
Snippet The abyssomicins are a structurally intriguing family of bioactive natural products that include compounds with potent antibacterial, antitumour and antiviral...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 14009
SubjectTerms Biosynthesis
Chemistry
Cycloaddition
Diels-Alder reactions
Dynamic structural analysis
Enantiomers
Molecular dynamics
Natural products
Stereoselectivity
Substrates
Title Antibiotic origami: selective formation of spirotetronates in abyssomicin biosynthesis
URI https://www.ncbi.nlm.nih.gov/pubmed/39144453
https://www.proquest.com/docview/3097821597/abstract/
https://www.proquest.com/docview/3093174368/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC11318650
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELaAS3up6DtAkVF7Det4HDvuDW1BCImqUkvFLYpfaqSug5rlwL9n7N2s2PbWa8Z5aGbi-cbzIuQTb4y1BmTplJWlqE1X6pRlYcGg_6ydqnOf7euv8vJGXN3WtztETrUwOWnfmv40_l6cxv5Xzq28W9jZlCc2-3Y9ryrURIQWs12yqwCe-Oh5_wVYz2rlTFSlrDmb-pKCnjkxWga8Br9tif6Bl39nST4xOxf75MUaL9Kz1Xe9JDs-viLP5tOYttfk51lMZR8D0mmactUt-s90zNNtcCOjm-JEOgSaourD0qfT7wQxaR9pZx5QQIsUX6f4lPEhIiIc-_ENubk4_zG_LNfDEkrLtVyWUsjOaQ9okBQaoGDQjhuB9t5bxzwPjXU8NY-TjQhgvGNOCM2CC8xXgpsAb8leHKJ_T6gRlWsUOOUqL7T12nDHFF4NzKpgWEE-Toxr71Y9MdocywbdfhHf55m95wU5mnjarv-LsYVUNoIoQ6uCnGzIyLEUpuiiH-7zGkh-kmwK8m4lgs1rQKMDKGooSLMlnM2C1C17m4JKlLtmT0pz8P-3HpLnHDFNOlKu-BHZW_659x8QkyzNcfblj7MiPgJ2AuWZ
link.rule.ids 230,315,733,786,790,870,891,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcigXKK8SaMEIrtl1bMeJuVXbVgt0KyRa6C2KHxERbFKR7KH8esbezarbnuCayfuzPd94XgDvWa6N0VzGNjMyFqkuY-WjLAzXaD8rm6WhzvbsTE4vxKfL9HIL5JALE4L2ja5Hza_5qKl_hNjKq7kZD3Fi4y-zSZLgSERqMb4H93HCsuyGlR5WYM5X3VoZFUksU0aHyqRcja3oDOUs5W5TF90hmLfjJG8onpNH8H145WW8yc_Rotcj8-dWNcd__6ZdeLjiouRwKX8MW655AjuToQXcU_h22PiUkhblxHfQKuf1B9KFzjm4SJJ14iNpK-I99m3v_M66p6-kbkiprxH8uffdE7xLd90g2-zq7hlcnByfT6bxqhFDbJiSfSyFLK1yHJVdhsqt0sgRtEAu4YyljlW5scwXppO5qLh2llohFK1sRV0imK74c9hu2sa9AKJFYvOM28wmTijjlGaWZni0oiarNI3g3QBJcbWst1EEPzlXxZH4OgnAHUewP6BVrOZcV3CfkoIMRmURvF2L8Y95F0jZuHYRzuHeBpN5BHtLcNeP4QqNS5HyCPIN2Ncn-ErcmxIEM1TkHsB7-f-XvoGd6fnstDj9ePb5FTxgyJ381nXC9mG7_71wB8h9ev06DPS_NcgG1Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BkYAL70eggBFcs3Fs52Fu1bar8mhVCYoqcYjil4ja9a5I9lB-PeNssuqWW6-x8_zszDee8TcAH1mptFY8j02h81hkqo5lyLLQXKH_LE2R9TrbR8f54an4cpadDVmV7ZBW6bVqJv5iPvHN7z63cjnXyZgnlpwcTdMURyJSi2RpXHIb7uCkZfKKp97_hTkfKrYyKtI4zxgd1Um5TIxoNeUs43bbHv1HMq_nSl4xPrOH8Gt87HXOyflk1amJ_ntN0fFm7_UIHgyclOyt-zyGW9Y_gXvTsRTcU_i558PWkgW2k1BJq543n0jbV9DBnyXZbIAkC0dC5H7R2bDCHmgsaTyp1SUOgnmI4RO8SnvpkXW2TfsMTmcHP6aH8VCQIdZM5l2ci7w20nI0egUaOaeQKyiBnMJqQy1zpTYsCNTlpXBcWUONEJI646hNBVOOP4cdv_D2JRAlUlMW3BQmtUJqKxUztMCjjurCKRrBhxGWarnW3aj6eDmX1b74Pu3BO4hgd0SsGuZeW_GwNQWZjCwieL9pxi8WQiG1t4tV34cHXywvI3ixBnhzGy7RyRQZj6Dcgn7TIShyb7cgoL0y9wjgq5uf-g7unuzPqm-fj7--hvsMKVRYwU7ZLux0f1b2DVKgTr3tx_o_YbEJVQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antibiotic+origami%3A+selective+formation+of+spirotetronates+in+abyssomicin+biosynthesis&rft.jtitle=Chemical+science+%28Cambridge%29&rft.au=Mbatha%2C+Sbusisiwe+Z.&rft.au=Back%2C+Catherine+R.&rft.au=Devine%2C+Andrew+J.&rft.au=Mulliner%2C+Hannah+M.&rft.date=2024-08-12&rft.pub=The+Royal+Society+of+Chemistry&rft.issn=2041-6520&rft.eissn=2041-6539&rft_id=info:doi/10.1039%2Fd4sc03253e&rft.externalDBID=PMC11318650
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-6520&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-6520&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-6520&client=summon